Erythrocyte sedimentation rate, plasma viscosity and C-reactive protein in clinical practice

British Journal of Hospital Medicine

Volumn 58, Issue 10, 1997, Pages 521-523

  Ng, Thomas ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; C REACTIVE PROTEIN;

BLOOD; BLOOD VISCOSITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFLAMMATION; METABOLISM; REVIEW;

BLOOD SEDIMENTATION; BLOOD VISCOSITY; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 0031578474     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Akhtar N, Thompson J, Durrant ST, Angl CA, Lauder I, Wood JK (1991) The clinical relevance of plasma viscosity in Hodgkin's disease. Clin Lab Haematol 13: 1-8
2. Custodi P, Cerutti A, Balduini CL (1996) Which tests are most useful to distinguish between clonal and reactive thrombocytosis [Letter], Am] Med 101: 233-5
3. Fowkes FGR, Lowe GDO, Rumley A, Lcnnie SE, Smith FB, Donnan PT (1993) Relation of blood viscosity to blood pressure in a random sample of population aged 55 to 74 years. Eur Heart] 14: 597-601
4. Green AE, Hickton MC (1994) Should plasma viscosity replace the ESR? BrJ Haematol 86: 896
5. Gudmundsson M, Nordborg E, Bengtsson BA, Bjelle A (1993) Plasma viscosity in giant cell arteritis as a predictor of disease activity. Ann Rheum Dis 52: 104-9
6. Gudmundsson M, Bjelle A (1995) Plasma viscosity in monitoring of therapy in rheumatoid arthritis patients. Scand J Rheumatol 24: 2\9-24
7. Harkness J (1963) A new instrument for the measurement ot plasma viscosity. Lancet ii: 280-1 imrie CW (1995) Prognosis of acute pancreatitis. Ann Ital Chir 66: 187-9
8. Ljungberg B, Grankvist K, Rasmuson T (1995) Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 76: 1435-9
9. Lowe GDO (1994) Clinical annotation: should plasma viscosity replace the ESR? BrJ Haematol 86: 6-11
10. Maseri A, Biasucci LM, Liuzzo G (1996) Inflammation in ischaemic heart disease: C-reactive protein concentration may provide useful information on risk. Br Med] 312: 1049-50
11. Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Anhr Rheum 24: 91-104
12. Pepys MB (1995) The acute phase response and C-rcactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Clinical Medicine. 3rd edn. Oxford University Press, Oxford: 1527-33
13. Schreiber S, Buyse M (1995) The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica. Clin Rheumatol 14: 315-18
14. Somer T (1987) Rheology of paraprotemaemia and the plasma hyperviscosity syndrome. In: Lowe GDO, ed. Bauliere's Clinical Haematology: International Practice and Research. Bailliere Tindall, London: 695-723
15. Wallach J (1992) Core blood analyses -alteration by disease. In: Wallach J. Interpretation of Diagnostic Tests: A Synopsis of Laboratory Medicine. 5th edn. Little, Brown and Company, London: 74-6
16. Westergren A (1921) Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta Med Scand 54: 247-82